Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer Read more
AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S. Read more
Immune Regulation Ltd Receives Notice of Allowance for New U.S. Patent for its Novel Protein with Anti-Inflammatory Properties Read more
Destiny Pharma and SporeGen announce collaboration and Innovate UK grant award to co-develop novel, preventative treatment for COVID-19 Read more
IcanoMAB GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19 Read more
HEUFT to host a free exclusive webinar on Pulsed x-ray technology & smart optics for a total inspection of pre-fillable syringe cannulas and needle shields Read more